EP Patent

EP2092068A2 — Optimized non-canonical zinc finger proteins

Assigned to Sangamo Therapeutics Inc · Expires 2009-08-26 · 17y expired

What this patent protects

Disclosed herein are zinc fingers comprising CCHC zinc coordinating residues. Also described are zinc finger proteins and fusion proteins comprising these CCHC zinc fingers as well as polynucleotides encoding these proteins. Methods of using these proteins for gene editing and ge…

USPTO Abstract

Disclosed herein are zinc fingers comprising CCHC zinc coordinating residues. Also described are zinc finger proteins and fusion proteins comprising these CCHC zinc fingers as well as polynucleotides encoding these proteins. Methods of using these proteins for gene editing and gene regulation are also described

Drugs covered by this patent

Patent Metadata

Patent number
EP2092068A2
Jurisdiction
EP
Classification
—
Expires
2009-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Sangamo Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.